NCT01873521

Brief Summary

It is hypothesized that the use of Neurally Adjusted Ventilatory Assist (NAVA) compared to pressure support to provide noninvasive ventilation to children will result in a decrease in the number of children with moderate to severe respiratory failure failing noninvasive ventilation and requiring endotracheal intubation. It is further hypothesized that noninvasive ventilation with NAVA compared to pressure support will result in a decrease in the length of mechanical ventilation, and the length of PICU and hospital stay.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Feb 2014

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 10, 2013

Completed
8 months until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

April 16, 2014

Status Verified

April 1, 2014

Enrollment Period

7 months

First QC Date

June 6, 2013

Last Update Submit

April 15, 2014

Conditions

Keywords

Positive Pressure VentilationNeurally Adjusted Ventilatory AssistPatient/ventilator AsynchronyPediatric patientInfant

Outcome Measures

Primary Outcomes (1)

  • Avoiding endotracheal intubation

    The primary objective of this study is to demonstrate that the use of NAVA to provide noninvasive ventilatory support (NIV NAVA) compared to pressure support (NIV PS) in pediatric patients with moderate to severe respiratory failure decreases the noninvasive ventilation failure rate by decreasing the number of patients requiring endotracheal intubation (ETI).

    During non invasive ventilation, an average of 2-3 days.

Secondary Outcomes (2)

  • Length (days) of PICU stay after NIV

    Length (days) of PICU stay after NIV, an average of 1 week.

  • Length (days) hospital stay after NIV

    Length (days) hospital stay after NIV, an average of 1-2 weeks

Study Arms (2)

NIV PS

ACTIVE COMPARATOR

The patients in this arms will received non invasive ventilation in PS mode.

Procedure: Non invasive ventilation

NIV NAVA

ACTIVE COMPARATOR

The patients in this arm will received non invasive ventilation in NAVA mode.

Procedure: Non invasive ventilation

Interventions

NIV NAVANIV PS

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age \> 1 month age or weight \> 3 Kg to 18 years
  • Not intubated.
  • Admitted to the PICU.
  • Minimally agitated/sedated: between -2 and +2 on the Richmond agitation-sedation scale (Table 2).
  • Moderate/severe Pediatric Acute Respiratory failure of any origin evaluated after a period of respiratory stabilization (aspiration of secretions, physiotherapy, oxygen and nebulized therapy) defined as: a) Modified Silverman-Wood Downess test \>or= 5 or \<or= 9; b) Hypoxemic ARF(SpO2\< 94% FiO2 0,5). c)Hypercapnic ARF (PaCO2 (mmHg) and/or pH \<7,30)
  • The attending pediatric intensive care physician believes that the patient is likely to require endotracheal intubation (ETI).

You may not qualify if:

  • Patients younger than 1 month or older than 18 year
  • Severe ARF defined as Modified Silverman-Wood Downes test \>9.
  • Patients who need immediate endotracheal intubation: i.e.: Severe ARF with signs of exhaustion
  • Facial trauma/burns
  • Recent facial, upper way, or upper gastrointestinal tract surgery excepting gastrostomy for feeding
  • Fixed obstruction of the upper airway.
  • Inability to protect airway
  • Life threatening hypoxemia defined as SpaO2 \<90% with FiO2 \> 0.8 on hi-flow oxygen.
  • Hemodynamic instability: refractory at volume expansion \>60 ml/kg and dopamine \>10 mcg/kg/min
  • Impaired consciousness defined as Glasgow coma scale \< 10.
  • Bowel obstruction.
  • Untreated pneumothorax.
  • Poor short term prognosis (high risk of death in the next 3 months)
  • Known esophageal problem (hiatal hernia, esophageal varicosities)
  • Active upper gastro-intestinal bleeding or any other contraindication to the insertion of a NG tube.
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario La Paz

Madrid, Madrid, 28046, Spain

RECRUITING

Related Publications (11)

  • Cheifetz IM. Invasive and noninvasive pediatric mechanical ventilation. Respir Care. 2003 Apr;48(4):442-53; discussion 453-8.

    PMID: 12667269BACKGROUND
  • Al-Mutairi SS, Al-Deen JS. Non-invasive positive pressure ventilation in acute respiratory failure. An alternative modality to invasive ventilation at a general hospital. Saudi Med J. 2004 Feb;25(2):190-4.

    PMID: 14968216BACKGROUND
  • L'HerE, Moriconi M, Texier F, Bouquin V, Kaba L, Renault A, Garo B, Boles JM. Non-invasive continuous positive airway pressure in acute hypoxaemic respiratory failure--experience of an emergency department. Eur J Emerg Med. 1998 Sep;5(3):313-8.

    PMID: 9827833BACKGROUND
  • Bernet V, Hug MI, Frey B. Predictive factors for the success of noninvasive mask ventilation in infants and children with acute respiratory failure. Pediatr Crit Care Med. 2005 Nov;6(6):660-4. doi: 10.1097/01.pcc.0000170612.16938.f6.

    PMID: 16276332BACKGROUND
  • Keenan SP, Sinuff T, Cook DJ, Hill NS. Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med. 2004 Dec;32(12):2516-23. doi: 10.1097/01.ccm.0000148011.51681.e2.

    PMID: 15599160BACKGROUND
  • Kendirli T, Kavaz A, Yalaki Z, Ozturk Hismi B, Derelli E, Ince E. Mechanical ventilation in children. Turk J Pediatr. 2006 Oct-Dec;48(4):323-7.

    PMID: 17290566BACKGROUND
  • Calderini E, Chidini G, Pelosi P. What are the current indications for noninvasive ventilation in children? Curr Opin Anaesthesiol. 2010 Jun;23(3):368-74. doi: 10.1097/ACO.0b013e328339507b.

    PMID: 20440111BACKGROUND
  • Essouri S, Durand P, Chevret L, Haas V, Perot C, Clement A, Devictor D, Fauroux B. Physiological effects of noninvasive positive ventilation during acute moderate hypercapnic respiratory insufficiency in children. Intensive Care Med. 2008 Dec;34(12):2248-55. doi: 10.1007/s00134-008-1202-9. Epub 2008 Aug 19.

    PMID: 18712350BACKGROUND
  • Breatnach C, Conlon NP, Stack M, Healy M, O'Hare BP. A prospective crossover comparison of neurally adjusted ventilatory assist and pressure-support ventilation in a pediatric and neonatal intensive care unit population. Pediatr Crit Care Med. 2010 Jan;11(1):7-11. doi: 10.1097/PCC.0b013e3181b0630f.

    PMID: 19593246BACKGROUND
  • Biban P, Serra A, Polese G, Soffiati M, Santuz P. Neurally adjusted ventilatory assist: a new approach to mechanically ventilated infants. J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:38-40. doi: 10.3109/14767058.2010.510018.

    PMID: 20828233BACKGROUND
  • Munoz-Bonet JI, Flor-Macian EM, Brines J, Rosello-Millet PM, Cruz Llopis M, Lopez-Prats JL, Castillo S. Predictive factors for the outcome of noninvasive ventilation in pediatric acute respiratory failure. Pediatr Crit Care Med. 2010 Nov;11(6):675-80. doi: 10.1097/PCC.0b013e3181d8e303.

    PMID: 20308933BACKGROUND

MeSH Terms

Conditions

Patient-Ventilator Asynchrony

Interventions

Noninvasive Ventilation

Condition Hierarchy (Ancestors)

Respiratory InsufficiencyRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Robert M Kacmarek, PhD RRT FCCM

    Massachusetts General Hospital, Boston, USA

    STUDY DIRECTOR
  • Jesús Villar, MD,PhD

    Hospital Universitario Dr. Negrin

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pedro De la Oliva, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

June 6, 2013

First Posted

June 10, 2013

Study Start

February 1, 2014

Primary Completion

September 1, 2014

Study Completion

December 1, 2016

Last Updated

April 16, 2014

Record last verified: 2014-04

Locations